Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
Table of Contents

SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, as amended, Orexigen Therapeutics, Inc. has duly caused this Amendment No. 3 to Registration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in San Diego, California on the 9th day of April, 2007.
 
OREXIGEN THERAPEUTICS, INC.
 
  By: 
/s/  Gary D. Tollefson
Gary D. Tollefson, M.D., Ph.D.
President and Chief Executive Officer
 
Pursuant to the requirements of the Securities Act of 1933, as amended, this Amendment No. 3 to Registration Statement on Form S-1 has been signed by the following persons in the capacities and on the dates indicated.
 
             
Signature
 
Title
 
Date
 
/s/  Gary D. Tollefson

Gary D. Tollefson, M.D., Ph.D.
  President, Chief Executive Officer and Director (Principal Executive Officer)   April 9, 2007
         
/s/  Graham K. Cooper

Graham K. Cooper
  Chief Financial Officer, Treasurer and Secretary (Principal Financial and Accounting Officer)   April 9, 2007
         
*

Eckard Weber, M.D.
  Chairman of the Board of Directors   April 9, 2007
         
*

Louis C. Bock
  Director   April 9, 2007
         
*

Brian H. Dovey
  Director   April 9, 2007
         
*

Joseph S. Lacob
  Director   April 9, 2007
         
*

Michael F. Powell, Ph.D.
  Director   April 9, 2007
         
*

Daniel K. Turner III
  Director   April 9, 2007
             
*By:  
/s/  Gary D. Tollefson

Gary D. Tollefson, M.D., Ph.D.
Attorney-in-Fact
       


II-5